Idiopathic Diffuse Pulmonary Neuroendocrine Cell Hyperplasia Associated with Twenty-Three Synchronous Typical Pulmonary Carcinoid Tumors in an Asymptomatic Patient: A Case Report
DOI:
https://doi.org/10.5281/zenodo.23104829Keywords:
lung neoplasms, Pulmonary Neuroendocrine Cell Hyperplasia, Carcinoid Tumor, thoracic surgeryAbstract
Introduction: Idiopathic diffuse pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare disease recognized as a precursor lesion of pulmonary neuroendocrine tumors. Its association with multiple synchronous pulmonary carcinoid tumors is exceptionally uncommon. The aim of this report is to describe the radiological and histopathological features that led to the diagnosis of DIPNECH in an asymptomatic patient. Case Presentation: A 70-year-old non-smoking woman with a history of cardiovascular disease and hypothyroidism was found to have an incidental 13-mm solid pulmonary nodule in the left lower lobe. Positron emission tomography demonstrated mild metabolic uptake, and follow-up imaging showed progressive growth. The patient went under a video-assisted thoracoscopic (VATS) left lower lobectomy with mediastinal lymph node dissection. Histopathological analysis identified twenty-three synchronous pulmonary neuroendocrine tumors, classified as grade 1 typical carcinoids measuring 2-11 mm, with a Ki-67 proliferation index of 2% and no lymph node involvement. Radiologic-pathologic correlation established the diagnosis of DIPNECH associated with multiple synchronous typical pulmonary carcinoid tumors. Discussion: DIPNECH is infrequent and underdiagnosed. Although its association with pulmonary carcinoid tumors has been well documented, the presence of twenty-three synchronous typical carcinoids in an asymptomatic patient is exceptional. This case shows the value of recognizing radiological findings suggestive of DIPNECH, particularly the simultaneity of multiple pulmonary micronodules and a mosaic attenuation pattern, which may precede a histopathological diagnosis. Early identification of these signs may facilitate diagnosis and contribute to timely management.
Downloads
References
1. Sun TY, Hwang G, Pancirer D, Hornbacker K, Codima A, Lui NS, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour. Eur Respir J [Internet]. 2022 [citado el 24 de junio de 2026]. Disponible en: https://doi.org/10.1183/13993003.01058-2021
2. O'Callaghan M, Forde SH, Franciosi AN, Penugonda M, Diesler R, O'Brien H, et al. Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. ERJ Open Res [Internet]. 2026 [citado el 24 de junio de 2026]. Disponible en: https://doi.org/10.1183/23120541.00829-2025
3. Samhouri BF, Halfdanarson TR, Koo CW, McCarthy C, Yi ES, Thomas CF, et al. DIPNECH: pragmatic approach, uncertainties, notable associations, and a proposal for an improved definition. Endocr Relat Cancer [Internet]. 2023 citado el 24 de junio de 2026]. Disponible en: https://doi.org/10.1530/ERC-23-0051
4. Almquist DR, Ernani V, Sonbol MB. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: DIPNECH. Curr Opin Pulm Med [Internet]. 2021 [citado el 24 de junio de 2026]. Disponible en: https://doi.org/10.1097/MCP.0000000000000776
5. Cassar P, Buhagiar D, Gauci J, Bartolo K, Mizzi A, Mallia A, et al. DIPNECH: a rare cause of slow-growing pulmonary nodules in a dyspnoeic patient with a history of breast cancer. Eur J Case Rep Intern Med [Internet]. 2024 [citado el 27 de Agosto de 2026]. Disponible en: https://doi.org/10.12890/2024_004870
6. Nassar AA, Jaroszewski DE, Helmers RA, Colby TV, Patel BM, Mookadam F. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Am J Respir Crit Care Med [Internet]. 2011 [citado el 24 de junio de 2026]. Disponible en: https://doi.org/10.1164/rccm.201010-1702CI
7. Chung C, Bommart S, Marchand-Adam S, Lederlin M, Fournel L, Charpentier MC, et al. Long-term imaging follow-up in DIPNECH. J Clin Med [Internet]. 2021 [citado el 24 de junio de 2026]. Disponible en: https://doi.org/10.3390/jcm10132950
8. Gutierrez M, Alonso A, Penha D, Ntouskou M, Gosney J, Radike M. Radiological-pathological correlation in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Clin Radiol [Internet]. 2024 [citado el 24 de junio de 2026]. Disponible en: https://doi.org/10.1016/j.crad.2023.10.013
9. Maki Y, Okada K, Nakamura R, Hirano Y, Fujiwara T, Yamasaki R, et al. A case of multiple lung carcinoid tumors localized in the right lower lobe. Respir Med Case Rep [Internet]. 2022 [citado el 24 de junio de 2026]. Disponible en: https://doi.org/10.1016/j.rmcr.2022.101679
10. Marchevsky AM, Wirtschafter E, Walts AE. The spectrum of changes in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Hum Pathol [Internet]. 2015 [citado el 24 de junio de 2026]. Disponible en: https://doi.org/10.1016/j.humpath.2014.10.015
11. Ramirez RA, Cass AS, Das S, Low SW, Mehrad M, Rickman OB, et al. A multidisciplinary approach to the work up and management of pulmonary carcinoid tumors and DIPNECH. Transl Lung Cancer Res [Internet]. 2022 [citado el 24 de junio de 2026]. Disponible en: https://doi.org/10.21037/tlcr-22-415
12. Baine MK, Rekhtman N. Update on pulmonary neuroendocrine tumors. Surg Pathol Clin [Internet]. 2020 [citado el 24 de junio de 2026]. Disponible en:https://doi.org/10.1016/j.path.2019.10.008
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Fernanda Reed Torres, Eduardo Rivera Paris, Andrés Stevenson Silva, Matías Beyer Diaz, Claudio Jara Bunster (Autor/a)

This work is licensed under a Creative Commons Attribution 4.0 International License.









